Kayne Anderson Rudnick Investment Management’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $65.4M | Buy |
83,946
+6,785
| +9% | +$5.29M | 0.16% | 120 |
|
2025
Q1 | $63.7M | Sell |
77,161
-4,587
| -6% | -$3.79M | 0.16% | 123 |
|
2024
Q4 | $63.1M | Sell |
81,748
-2,987
| -4% | -$2.31M | 0.15% | 125 |
|
2024
Q3 | $75.1M | Sell |
84,735
-1,227
| -1% | -$1.09M | 0.17% | 115 |
|
2024
Q2 | $77.8M | Sell |
85,962
-3,466
| -4% | -$3.14M | 0.19% | 114 |
|
2024
Q1 | $69.6M | Sell |
89,428
-1,921
| -2% | -$1.49M | 0.16% | 124 |
|
2023
Q4 | $53.2M | Sell |
91,349
-2,809
| -3% | -$1.64M | 0.13% | 132 |
|
2023
Q3 | $50.6M | Sell |
94,158
-3,141
| -3% | -$1.69M | 0.14% | 129 |
|
2023
Q2 | $45.6M | Buy |
97,299
+31,671
| +48% | +$14.9M | 0.13% | 134 |
|
2023
Q1 | $22.5M | Sell |
65,628
-2,002
| -3% | -$688K | 0.07% | 178 |
|
2022
Q4 | $24.7M | Buy |
67,630
+35,587
| +111% | +$13M | 0.08% | 173 |
|
2022
Q3 | $10.4M | Buy |
32,043
+29,879
| +1,381% | +$9.66M | 0.03% | 245 |
|
2022
Q2 | $702K | Sell |
2,164
-122
| -5% | -$39.6K | ﹤0.01% | 361 |
|
2022
Q1 | $655K | Buy |
2,286
+328
| +17% | +$94K | ﹤0.01% | 360 |
|
2021
Q4 | $541K | Buy |
1,958
+11
| +0.6% | +$3.04K | ﹤0.01% | 369 |
|
2021
Q3 | $450K | Buy |
1,947
+55
| +3% | +$12.7K | ﹤0.01% | 367 |
|
2021
Q2 | $434K | Sell |
1,892
-200
| -10% | -$45.9K | ﹤0.01% | 365 |
|
2021
Q1 | $391K | Hold |
2,092
| – | – | ﹤0.01% | 366 |
|
2020
Q4 | $353K | Hold |
2,092
| – | – | ﹤0.01% | 364 |
|
2020
Q3 | $310K | Buy |
2,092
+1,406
| +205% | +$208K | ﹤0.01% | 358 |
|
2020
Q2 | $113K | Buy |
686
+200
| +41% | +$32.9K | ﹤0.01% | 375 |
|
2020
Q1 | $67K | Hold |
486
| – | – | ﹤0.01% | 381 |
|
2019
Q4 | $64K | Hold |
486
| – | – | ﹤0.01% | 378 |
|
2019
Q3 | $54K | Hold |
486
| – | – | ﹤0.01% | 370 |
|
2019
Q2 | $54K | Buy |
+486
| New | +$54K | ﹤0.01% | 365 |
|